How to get peptides prescribed legally in 2026

The short answer: a licensed prescriber can lawfully prescribe any FDA-approved peptide drug, such as tesamorelin, tirzepatide, semaglutide, or bremelanotide. [1] [2] [3] [4] A compounding pharmacy can fill a narrower set of peptides that meet the federal compounding rules. Most of the healing, "anti-aging," and muscle peptides sold online meet none of those conditions today, so no prescription makes them lawful.

This guide explains which peptides fall into which group, what the pending FDA rule could change, how telehealth fits in, and what a legitimate visit looks like. It does not give doses or protocols. If you are new to the topic, start with what peptide therapy is.

Which peptides can a doctor legally prescribe today?

There are two lawful routes, and a peptide has to fit one of them.

Route 1: an FDA-approved drug. A prescriber may write for an approved drug for its labeled use and, using medical judgment, off label. The approved peptides most often asked about are:

• Tirzepatide and semaglutide for chronic weight management and related conditions, as Zepbound and Wegovy. [2] [3]
• Tesamorelin as Egrifta, approved to reduce excess abdominal fat in adults with HIV and lipodystrophy. [1] Our HIV lipodystrophy page covers that indication.
• Bremelanotide (PT-141) as Vyleesi, for acquired, generalized hypoactive sexual desire disorder in premenopausal women. [4]

Route 2: a lawfully compounded peptide. Under section 503A, a state-licensed pharmacy may compound for an individual patient with a prescription, using a bulk ingredient only if it is a component of an approved drug, has a USP or NF monograph, or appears on FDA's 503A bulks list. [5] Compounded drugs are not FDA approved, and FDA does not review them before they are sold. [6]

Biologics are the exception to route 2. Among the peptides clinics most often sell for body composition, tesamorelin fits route 1 only: it is an approved drug, but tesamorelin is a biologic: Egrifta moved to a biologics license (BLA 022505) on March 23, 2020, and FDA states that biological products are not eligible for the 503A or 503B compounding exemptions, so compounded tesamorelin has no lawful basis. [6] [20] Egrifta WR by prescription is the only lawful product; see tesamorelin cost and our tesamorelin prescription guide.

Sermorelin is a gray zone. Its brand, Geref, was discontinued, and FDA later found it was not withdrawn for safety or effectiveness reasons. [12] Many 503A pharmacies compound it on the basis of that former approval; whether that holds up depends on the pharmacy and its state board. The sermorelin vs tesamorelin comparison covers both.

Which peptides are waiting on FDA, and what would a final rule change?

In April 2026 FDA moved a group of peptides off Category 2, its list of bulk substances that raise significant safety concerns. [9] On July 23 to 24, 2026, its Pharmacy Compounding Advisory Committee (PCAC) voted to recommend adding six to the 503A bulks list: BPC-157, KPV, TB-500, MOTS-c, semax, and epitalon. [10]

A recommendation is not a rule. A substance joins the bulks list only through notice-and-comment rulemaking and a final rule, the process FDA used for its first bulks-list rule in 2019. [8] Until that happens, none of the six is on the list, and a 503A pharmacy has no federal basis to compound them from bulk. [7]

If FDA publishes a final rule listing a peptide, it would change one thing: a licensed 503A pharmacy could compound it for an individual patient with a prescription. It would not make the peptide an approved drug, would not create an approved dose, and would not open 503B outsourcing, which runs on a separate list. [11] The evidence would also be unchanged; BPC-157, for example, is still graded animal only. Track each step on the BPC-157 regulatory tracker and the full regulatory feed.

Which peptides have no lawful path?

CJC-1295, ipamorelin, selank, thymosin alpha-1, injectable GHK-Cu, 5-amino-1MQ, and melanotan II are not approved drugs and are not on the 503A bulks list. [7] No prescription changes that. Blends inherit their strictest ingredient, so a CJC-1295 and ipamorelin blend has no lawful path either.

Retatrutide is a special case. It is an investigational drug in phase 3 trials, not approved, and not compoundable, and FDA has warned about unapproved GLP-1 products sold online, retatrutide among them. [13] The lawful routes are a clinical trial, which you can search on ClinicalTrials.gov, or FDA expanded access, which is meant for people with serious conditions who cannot join a trial. [14] [15] Our guide on how to get retatrutide walks through both.

Can you get peptides prescribed online through telehealth?

Yes, for lawful products. The prescriber must be licensed in the state where you are located at the time of the visit. The federal rule requiring an in-person evaluation before prescribing controlled substances over the internet applies to controlled substances; the peptide drugs discussed here are not in that group. [16] Each state then sets its own rules for creating a valid telehealth relationship. Texas, for example, lists the methods that qualify, including synchronous audio-video visits. [17] Our Texas guide and the other state legal guides cover the details.

How to get peptides for weight loss

The lawful and best-studied options are the approved GLP-1 drugs, prescribed by a licensed clinician in person or by telehealth and filled at a licensed pharmacy. [2] [3] Routine compounded copies of semaglutide and tirzepatide ended when their shortages did; see our compounded tirzepatide guide. The GLP-1 hub collects prices and state access, the obesity condition page grades each option, and our weight loss ranking orders them by human evidence.

How to get peptides for muscle growth

No peptide is FDA approved to build muscle in healthy adults. Tesamorelin is approved to reduce abdominal fat in a specific HIV population, not to add muscle. [1] The growth hormone secretagogues sold for muscle, such as CJC-1295 and ipamorelin, have no lawful path, and growth-hormone-releasing peptides are prohibited in sport under WADA section S2. [18] Our muscle growth ranking and does tesamorelin build muscle cover the evidence.

What a legitimate peptide visit includes

A lawful prescription looks like ordinary medical care:

1. A real evaluation. History, current medications, and the contraindications on the label, such as the boxed thyroid tumor warning on GLP-1 drugs. [2]
2. A named product and pharmacy. You should know whether you are getting an approved drug or a compounded one, and which licensed pharmacy fills it. [6]
3. A reason for compounding, if used. For copies of approved drugs, federal law requires a change that makes a significant difference for you. [5]
4. A plan for monitoring and follow-up, including what to do about side effects.

Where to get peptide therapy: checking the pharmacy

Ask for the dispensing pharmacy's name and look up its license with your state board of pharmacy, including a nonresident license if it ships across state lines. FDA's BeSafeRx campaign lists the basics: a legitimate online pharmacy requires a prescription, is licensed in your state, and has a licensed pharmacist to answer questions. [19] Our provider verification guide explains how we check listings.

What's actually offered, and what that means for you

Licensed compounding pharmacies, clinics, and telehealth prescribers do offer many of the peptides in the awaiting-rule and no-lawful-path groups above, and prescribers write prescriptions for them. That does not change the legal facts: BPC-157 and the other five PCAC peptides still await an FDA final rule, [10] and peptides that are not approved and not on the 503A bulks list have no lawful compounding path. [7]

Enforcement is uneven. FDA mostly acts through warning letters to compounders and online sellers, its Category 2 safety list, and import alerts that let it detain peptide shipments, with a separate alert for GLP-1 bulk substances that names retatrutide, rather than stopping every pharmacy. [9] [21] [22] [23] [24] State boards of pharmacy oversee pharmacies day to day, and their rules differ. [6] [25]

What changes for you:

• No FDA review of the product. FDA does not verify a compounded drug's safety, effectiveness, or quality before it is sold. [6]
• Identity, purity, sterility, and dose accuracy vary. FDA has cited impurities and immunogenicity risk for several of these peptides. [9]
• Insurance rarely pays, because there is no approved indication to match, so you usually pay cash.
• Sport. Most are prohibited for tested athletes on the WADA list. [18]

Check for a 503A pharmacy licensed in your state, a real evaluation by a licensed prescriber rather than an online form, and a certificate of analysis for the specific batch. These checks lower some risks, but they do not make an unlawfully compounded product lawful or safe. Where an approved option exists, choose it: tesamorelin as Egrifta WR, [1] approved GLP-1 drugs such as tirzepatide and semaglutide instead of retatrutide, [2] [3] and bremelanotide as Vyleesi for its approved use. [4]

Red flags: research use only and other warning signs

• "Research use only" or "not for human consumption" labels. These are not prescription products, and FDA warns they may contain the wrong ingredient or dose. [13]
• No prescriber, or a checkbox form in place of a visit.
• Peptides with no lawful path sold as routine prescriptions. [7]
• Stacks sold as protocols. No trial has tested the popular combinations.
• Claims that a compounded product is "the same as" an approved brand. Compounded drugs are not approved generics. [6]

The lawful list is short today, and it may grow if FDA finalizes the PCAC recommendations. Until then, the safest question to ask any program is simple: is this an approved drug, a lawfully compounded prescription, or neither?